| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
41 |
| Equity
Latest Equity |
13.21 |
| Face Value
Latest Face Value |
2 |
| Reserves
Total Reserve |
230.59 |
| Dividend
Full Year Dividend % |
200 |
| Sales Turnover
Full Year Net Sales |
287.23 |
| Net Profit
Full Year Net Profit |
44.64 |
| Full Year CPS
Full Year Cash Per Share |
8.2 |
| Earning Per Share
Full Year Earning Per Share |
6.8 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Sep 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
81.38 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
36.9 |
| Networth
Full Year Return on Networth |
16.69 |
| Price/Book Value
Price to Book value |
5.934959 |
| Yearly PE ratio
Full Year Price to Earning per share |
32.4 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
26.7 |
| Bse value
BSE Value in lakhs |
6.16 |
| Nse value
NSE Value in lakhs |
108.37 |
| High
52 week high |
265 |
| Low
52 week low |
155 |
| Price
NSE Current market price |
220 |
| CPM
Current market price |
219 |
| Market cap
BSE / NSE Market Cap |
1449.34 |
| Net profit
Latest Quarter Net Profit |
12.77 |
| Net profit variance
Latest Quarter Net Profit variance |
2 |
| Result year
Trailing latest month |
Sep 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
226.85 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
31.62 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
13.94 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
69.32 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
23.05 |
| TTM NP
Trailing Twelve 12 month Net Profit |
26.76 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
7.91 |
| TTM EPS
Trailing Twelve 12 month EPS |
7.15 |
| TTM PE
Trailing Twelve 12 month PE |
30.69 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
4.23 |
| Equity
Latest Equity |
13.21 |
| LTP
Latest Price (BSE/NSE) |
219 |
| Gross block
Latest Gross Block |
102 |
| Loans
Total loans |
8.17 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
20.2 |
| Year GPM
Full Year Gross Profit Margin |
24 |
| Quarter OPM
Latest quater Operation Profit Margin |
20.6 |
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 74 | 59 | 76 | 74 | 73 | 64 | 82 | 96 |
| YOY Sales Growth % | 57% | 35% | 23% | -0% | -1% | 10% | 9% | 29% |
| Gross Sales | 74 | 59 | 76 | 74 | 73 | 64 | 82 | 96 |
| + Expenses | 58 | 50 | 61 | 58 | 59 | 53 | 65 | 80 |
| Material Cost % | 7% | 5% | 8% | 6% | 6% | 3% | 9% | 4% |
| Raw Material Cost | 5 | 3 | 5 | 4 | 4 | 3 | 5 | 5 |
| Change in Inventory | 0 | -1 | 1 | 0 | 0 | -1 | 2 | 0 |
| Manufacturing Cost % | 18% | 20% | 20% | 17% | 20% | 21% | 17% | 16% |
| Employee Cost % | 24% | 28% | 26% | 24% | 24% | 24% | 28% | 24% |
| Other Cost % | 29% | 32% | 27% | 31% | 30% | 34% | 26% | 38% |
| Raw Materials % | 7% | 6% | 7% | 5% | 5% | 5% | 6% | 5% |
| Purchase of Finished Goods % | 29% | 30% | 30% | 32% | 31% | 31% | 32% | 37% |
| Stock Adjustments % | 0% | 1% | -1% | -1% | -0% | 1% | -3% | 0% |
| Other Manufacturing Expenses % | 18% | 20% | 20% | 17% | 20% | 21% | 17% | 16% |
| Operating Profit | 16 | 9 | 14 | 16 | 14 | 11 | 17 | 17 |
| OPM % | 21% | 15% | 19% | 22% | 19% | 17% | 21% | 17% |
| + Other Income | 26 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Miscellaneous Income | 26 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Exceptional Income | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 39 | 9 | 14 | 17 | 15 | 12 | 18 | 16 |
| + Tax % | 17% | 24% | 25% | 25% | 25% | 25% | 25% | 25% |
| Current Tax | 8 | 1 | 3 | 4 | 4 | 2 | 4 | 4 |
| Deferred Tax | -1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| + Net Profit | 32 | 7 | 11 | 13 | 11 | 9 | 13 | 12 |
| Extraordinary Income / Expense | 23 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Exceptional Item | 23 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Net Profit After Minority Interest | 13 | 12 | ||||||
| EPS in Rs | 2.00 | 1.86 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 145 | 127 | 167 | 159 | 188 | 218 | 237 | 209 | 269 | 287 |
| Sales Growth % | -13% | 32% | -5% | 19% | 16% | 9% | -12% | 29% | 7% | |
| Gross Sales | 143 | 126 | 167 | 159 | 188 | 219 | 237 | 209 | 269 | 287 |
| Excise Duty | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 139 | 138 | 158 | 150 | 169 | 193 | 206 | 186 | 221 | 231 |
| Material Cost % | 41% | 48% | 44% | 35% | 43% | 41% | 39% | 38% | 36% | 36% |
| Raw Material Cost | 67 | 65 | 53 | 55 | 76 | 83 | 88 | 76 | 99 | 105 |
| Change in Inventory | -8 | -4 | 19 | 1 | 5 | 6 | 4 | 4 | -2 | -1 |
| Manufacturing Cost % | 2% | 2% | 1% | 1% | 1% | 1% | 0% | 0% | 1% | 1% |
| Employee Cost % | 28% | 33% | 28% | 32% | 29% | 27% | 28% | 30% | 26% | 25% |
| Other Cost % | 25% | 26% | 22% | 27% | 18% | 20% | 20% | 20% | 20% | 19% |
| Raw Materials % | 46% | 51% | 32% | 35% | 40% | 38% | 37% | 36% | 37% | 37% |
| Purchase of Finished Goods % | 9% | 23% | 9% | 11% | 20% | 23% | 24% | 26% | 30% | 31% |
| Stock Adjustments % | 6% | 3% | -12% | -1% | -3% | -3% | -2% | -2% | 1% | 0% |
| Power & Fuel % | 1% | 1% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Manufacturing Expenses % | 1% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
| Selling & Administration % | 21% | 22% | 19% | 24% | 17% | 20% | 18% | 20% | 18% | 18% |
| Miscellaneous Expenses % | 3% | 4% | 2% | 3% | 1% | 1% | 3% | 1% | 2% | 1% |
| Operating Profit | 6 | -11 | 9 | 9 | 19 | 25 | 31 | 23 | 47 | 56 |
| OPM % | 4% | -9% | 6% | 5% | 10% | 12% | 13% | 11% | 18% | 19% |
| + Other Income | 13 | 0 | 1 | 3 | 4 | 3 | 6 | 9 | 32 | 12 |
| Miscellaneous Income | 13 | 0 | 1 | 3 | 4 | 3 | 6 | 9 | 31 | 12 |
| Exceptional Income | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 0 |
| Interest | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 2 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 |
| Profit before tax | 14 | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 58 |
| + Tax % | 18% | 1% | 20% | 16% | 22% | 29% | 23% | 25% | 21% | 25% |
| Current Tax | 3 | 0 | 2 | 2 | 6 | 7 | 8 | 8 | 14 | 13 |
| Deferred Tax | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 1 | 1 |
| + Net Profit | 12 | -12 | 7 | 8 | 17 | 19 | 27 | 22 | 55 | 43 |
| Profit Growth % | -197% | -162% | 9% | 117% | 12% | 40% | -16% | 146% | -22% | |
| Extraordinary Income / Expense | 13 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 20 | -2 |
| Exceptional Item | 13 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 20 | -2 |
| EPS in Rs |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 97 | 85 | 91 | 98 | 109 | 120 | 146 | 174 | 226 | 261 |
| + Borrowings | 8 | 8 | 4 | 5 | 7 | 0 | 6 | 9 | 9 | 8 |
| Secured Borrowings | 0 | 0 | -2 | -2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unsecured Borrowings | 8 | 8 | 6 | 6 | 7 | 0 | 6 | 9 | 9 | 8 |
| + Other Liabilities | 25 | 23 | 28 | 31 | 35 | 31 | 30 | 21 | 29 | 34 |
| Current Liabilities | 25 | 23 | 28 | 31 | 36 | 31 | 31 | 22 | 30 | 34 |
| Provisions | 5 | 5 | 7 | 8 | 5 | 1 | 0 | 1 | 1 | 2 |
| Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other liability items | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 |
| Total Liabilities | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| + Fixed Assets | 22 | 21 | 22 | 22 | 26 | 23 | 24 | 9 | 94 | 85 |
| Gross Block | 53 | 54 | 55 | 56 | 60 | 58 | 33 | 12 | 103 | 102 |
| Accumulated Depreciation | 31 | 32 | 33 | 34 | 34 | 36 | 9 | 2 | 9 | 17 |
| CWIP | 0 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 11 | 15 | 51 | 1 | 0 | 0 | 0 |
| + Other Assets | 121 | 105 | 110 | 109 | 123 | 91 | 170 | 208 | 184 | 231 |
| Inventories | 48 | 51 | 33 | 29 | 30 | 30 | 21 | 15 | 15 | 15 |
| Trade receivables | 39 | 25 | 21 | 21 | 13 | 16 | 21 | 11 | 13 | 17 |
| Cash Equivalents | 20 | 15 | 39 | 38 | 60 | 25 | 115 | 148 | 129 | 106 |
| Loans n Advances | 3 | 4 | 6 | 6 | 15 | 18 | 10 | 25 | 6 | 8 |
| Other asset items | 11 | 11 | 13 | 14 | 6 | 3 | 3 | 9 | 20 | 86 |
| Total Assets | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | -3 | -2 | 31 | 11 | 28 | 7 | 47 | 35 | 55 | 47 |
| Profit Before Tax & Extraordinary Items | 14 | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 58 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 |
| Interest (Net) | 3 | 1 | 1 | 1 | -2 | -1 | -3 | -8 | -7 | -11 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit / Loss on Sale of Investments | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | -13 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 0 |
| Receivables | 2 | 14 | 4 | -1 | 9 | -3 | -6 | 9 | -2 | -4 |
| Inventories | -8 | -4 | 19 | 3 | 0 | 0 | 9 | 5 | 0 | 1 |
| Trade Payables | -1 | 0 | 3 | 0 | 6 | -1 | -2 | -9 | 2 | 2 |
| Direct Taxes Paid | -3 | 0 | 2 | -2 | -3 | -7 | -7 | -9 | -8 | -12 |
| + Cash from Investing Activity | 41 | -3 | -1 | -11 | -2 | -26 | -58 | -25 | -45 | -36 |
| Purchase of Fixed Assets | 0 | -4 | -2 | -2 | 0 | -1 | 0 | 0 | 0 | 0 |
| Sale of Fixed Assets | 43 | 0 | 1 | 3 | 0 | 1 | 1 | 0 | 36 | 0 |
| Purchase of Investments | 0 | 0 | 0 | -11 | -4 | -25 | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 41 | 1 | 0 | 0 |
| Interest Received | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 7 | 8 | 10 |
| Others | -2 | 0 | 0 | 0 | 0 | -1 | -103 | -33 | -88 | -46 |
| + Cash from Financing Activity | -34 | -1 | -6 | -1 | -7 | -18 | 0 | -9 | -12 | -12 |
| Proceeds from Issue of Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 3 | 7 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Proceeds from Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 | 0 |
| Repayment of Short-Term Borrowings | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
| Dividend Paid | 0 | 0 | -1 | -1 | -3 | -10 | 0 | -13 | -13 | -17 |
| Others | -30 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 5 | -6 | 24 | 0 | 19 | -36 | -11 | 2 | -2 | -1 |